What is KnipBio?
KnipBio operates at the intersection of biotechnology and sustainable agriculture, specializing in the development of JUV, an all-natural fermented ingredient engineered to optimize fish feed performance. The company addresses critical industry challenges by enhancing juvenile survival rates, bolstering stress resilience, and improving overall health outcomes in commercial aquaculture. By focusing on holistic nutrition, KnipBio provides a scalable solution that directly impacts farm profitability and operational efficiency. Their market position is defined by a commitment to evidence-based results, supported by extensive trials across diverse aquatic species, positioning them as a key innovator in the global feed additive market.
How much funding has KnipBio raised?
KnipBio has raised a total of $6.3M across 5 funding rounds:
Series A
$1.6M
Private Equity
$2.5M
Series B
$2M
Debt
$150K
Debt
$77K
Series A (2015): $1.6M with participation from Cherrystone Angel Group and Walnut Venture
Private Equity (2016): $2.5M, investors not publicly disclosed
Series B (2017): $2M supported by CherryStone Angel Group and LaunchPad Venture Group
Debt (2020): $150K featuring PPP
Debt (2021): $77K backed by PPP
Key Investors in KnipBio
LaunchPad Venture Group
Launchpad Venture Group is a network of angel investors focused on providing financial and human capital investments in early-stage tech and science-driven startups based in New England.
Cherrystone Angel Group
An angel investment group that provides early-stage capital and strategic guidance to high-growth potential startups in the New England region.
Walnut Venture
A venture firm specializing in early-stage investments, providing the necessary financial backing and mentorship to help startups scale their operations effectively.
What's next for KnipBio?
With the recent influx of capital, KnipBio is poised to accelerate its commercialization strategy and expand its global footprint. The company's roadmap likely involves scaling production capacity to meet the rising demand for high-performance, sustainable feed ingredients. Strategic priorities will likely include deepening market penetration in key aquaculture regions and continuing research into advanced nutritional profiles. As the firm matures, the focus will shift toward long-term enterprise sustainability, leveraging its proven efficacy to become a standard-bearer for health-focused aquaculture nutrition. Investors and industry stakeholders will be monitoring the company's ability to translate its technological breakthroughs into sustained, large-scale commercial adoption.
See full KnipBio company page
